Boehringer's profit up 1.4% as Jardiance gains offset impairments

German unlisted drugmaker Boehringer Ingelheim said on Wednesday its operating income rose 1.4% in 2022, as more prescriptions of diabetes drug Jardiance trumped higher energy costs and the effect... | March 29, 2023

Related Keywords

Ludwig Burger ,Eli Lilly ,Matthias Williams ,Astrazeneca ,Family Owned Boehringer ,Louise Heavens ,Astrazeneca Plc Stock Exchange ,News ,Information ,Press Release ,German ,Unlisted ,Drugmaker ,Boehringer ,Ingelheim ,Aid ,N ,Wednesday ,Its ,Operating ,Income ,Nose ,Us ,More ,Prescriptions ,F ,Diabetes ,Drug ,Ijardiance ,Etrumped ,Higher ,Energy ,Costs ,End ,The Azn Gb0009895292 ,